Hoth Therapeutics Announces New Pipeline Asset, HT-TBI for Stroke and Traumatic Brain Injury
HT-TBI is a novel, point-of-care drug-device combination product under development for acute treatment of secondary brain injury resulting from is...
Source: businessinsider.com